TraceLink picks up $51.5 mln Series C
North Reading, Massachusetts-based TraceLink, a network that connects the life sciences supply chain, has secured $51.5 million in Series C funding. Goldman Sachs Growth Equity led the round with participation from return backers FirstMark Capital, Volition Capital and F-Prime Capital. In conjunction with the funding, Jason Kreuziger of Goldman Sachs and Amish Jani of FirstMark Capital, have been added to TraceLink's board of directors.
30 November 2016•1 min read
